- Home
- TLSI vs HFFG Comparison
TLSI vs HFFG Comparison
Compare TLSI & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | HFFG |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 127.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | HFFG |
|---|---|---|
| Price | $6.17 | $2.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 208.1K | 108.2K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,207,000.00 | ★ $1,225,541,000.00 |
| Revenue This Year | $55.06 | $4.36 |
| Revenue Next Year | $46.04 | $3.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | 4.10 |
| 52 Week Low | $3.42 | $1.70 |
| 52 Week High | $7.95 | $4.93 |
Technical Indicators
Market Signals| Indicator | TLSI | HFFG |
|---|---|---|
| Relative Strength Index (RSI) | 41.04 | 35.41 |
| Support Level | $6.61 | $2.16 |
| Resistance Level | $7.95 | $2.29 |
| Average True Range (ATR) | 0.46 | 0.12 |
| MACD | -0.19 | -0.04 |
| Stochastic Oscillator | 0.80 | 9.57 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.